Agios Pharmaceuticals AGIO Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's common stock shares issued?
- Agios Pharmaceuticals (AGIO) reported common stock shares issued of 75.6M in Q1 2026.
- How has Agios Pharmaceuticals's common stock shares issued changed year-over-year?
- Agios Pharmaceuticals's common stock shares issued increased by 2.0% year-over-year, from 74.1M to 75.6M.
- What is the long-term trend for Agios Pharmaceuticals's common stock shares issued?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock shares issued has grown at a 1.5% compound annual growth rate (CAGR), from 69.3M to 74.7M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.